These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 28338509)

  • 1. Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.
    Groot VP; Rezaee N; Wu W; Cameron JL; Fishman EK; Hruban RH; Weiss MJ; Zheng L; Wolfgang CL; He J
    Ann Surg; 2018 May; 267(5):936-945. PubMed ID: 28338509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of the Pattern of Disease Recurrence on Survival Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.
    Groot VP; Gemenetzis G; Blair AB; Ding D; Javed AA; Burkhart RA; Yu J; Borel Rinkes IH; Molenaar IQ; Cameron JL; Fishman EK; Hruban RH; Weiss MJ; Wolfgang CL; He J
    Ann Surg Oncol; 2018 Aug; 25(8):2475-2483. PubMed ID: 29948425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictors and patterns of the early recurrence of pancreatic ductal adenocarcinoma after pancreatectomy: the influence of pre- and post- operative adjuvant therapy.
    Suto H; Okano K; Oshima M; Ando Y; Takahashi S; Shibata T; Kamada H; Kobara H; Masaki T; Suzuki Y
    BMC Surg; 2019 Dec; 19(1):186. PubMed ID: 31796066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma.
    Guo SW; Shen J; Gao JH; Shi XH; Gao SZ; Wang H; Li B; Yuan WL; Lin L; Jin G
    Surgery; 2020 Dec; 168(6):1003-1014. PubMed ID: 32321665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perineural Invasion of Pancreatic Ductal Adenocarcinoma is Associated with Early Recurrence after Neoadjuvant Therapy Followed by Resection.
    Cha DE; Yu AT; Khajoueinejad N; Gleeson E; Shaltiel T; Berger Y; Macfie R; Golas BJ; Sarpel U; Labow DM; Hiotis S; Cohen NA
    World J Surg; 2023 Jul; 47(7):1801-1808. PubMed ID: 37014430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence and survival after surgery for pancreatic cancer with or without acute pancreatitis.
    Feng Q; Li C; Zhang S; Tan CL; Mai G; Liu XB; Chen YH
    World J Gastroenterol; 2019 Oct; 25(39):6006-6015. PubMed ID: 31660036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma: A Bi-institutional Analysis.
    Malleo G; Maggino L; Ferrone CR; Marchegiani G; Warshaw AL; Lillemoe KD; Bassi C; Castillo CF; Salvia R
    Ann Surg; 2020 Jun; 271(6):1148-1155. PubMed ID: 30339622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
    Kim NH; Kim HJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological variables and risk factors for lung recurrence after resection of pancreatic ductal adenocarcinoma.
    Asakura Y; Toyama H; Ishida J; Asari S; Terai S; Shirakawa S; Yamashita H; Shimizu T; Ogura Y; Matsumoto I; Gon H; Tsugawa D; Komatsu S; Kuramitsu K; Yanagimoto H; Kido M; Ajiki T; Fukumoto T
    Asian J Surg; 2023 Jan; 46(1):207-212. PubMed ID: 35370072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant Therapy in Pancreas Cancer: Does It Influence Patterns of Recurrence?
    Parikh AA; Maiga A; Bentrem D; Squires MH; Kooby DA; Maithel SK; Weber SM; Cho CS; Katz M; Martin RC; Scoggins CR; Sutton J; Ahmad SA; Abbott DE; Carr J; Kim HJ; Yakoub D; Idrees K; Merchant N
    J Am Coll Surg; 2016 Apr; 222(4):448-56. PubMed ID: 26895735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of familial pancreatic cancer on postoperative outcome in pancreatic cancer: relevance to adjuvant chemotherapy.
    Tezuka K; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
    J Gastroenterol; 2021 Jan; 56(1):101-113. PubMed ID: 33094352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The canary in the coal mine: the growth of patient-derived tumorgrafts in mice predicts clinical recurrence after surgical resection of pancreatic ductal adenocarcinoma.
    Thomas RM; Truty MJ; Kim M; Kang Y; Zhang R; Chatterjee D; Katz MH; Fleming JB
    Ann Surg Oncol; 2015; 22(6):1884-92. PubMed ID: 25404477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of completion pancreatectomy for recurrence of adenocarcinoma in the remnant pancreas.
    Nakayama Y; Sugimoto M; Gotohda N; Konishi M; Takahashi S
    J Surg Res; 2018 Jan; 221():15-23. PubMed ID: 29229121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival.
    Belfiori G; Crippa S; Francesca A; Pagnanelli M; Tamburrino D; Gasparini G; Partelli S; Andreasi V; Rubini C; Zamboni G; Falconi M
    Ann Surg Oncol; 2021 Dec; 28(13):8249-8260. PubMed ID: 34258720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer.
    Honselmann KC; Pergolini I; Castillo CF; Deshpande V; Ting D; Taylor MS; Bolm L; Qadan M; Wellner U; Sandini M; Bausch D; Warshaw AL; Lillemoe KD; Keck T; Ferrone CR
    Ann Surg; 2020 Aug; 272(2):357-365. PubMed ID: 32675550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis.
    de Rooij T; Tol JA; van Eijck CH; Boerma D; Bonsing BA; Bosscha K; van Dam RM; Dijkgraaf MG; Gerhards MF; van Goor H; van der Harst E; de Hingh IH; Kazemier G; Klaase JM; Molenaar IQ; Patijn GA; van Santvoort HC; Scheepers JJ; van der Schelling GP; Sieders E; Busch OR; Besselink MG;
    Ann Surg Oncol; 2016 Feb; 23(2):585-91. PubMed ID: 26508153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting recurrence after left‑sided pancreatectomy for pancreatic ductal adenocarcinoma.
    Xia T; Xu P; Mou Y; Zhang X; Song S; Zhou Y; Lu C; Zhu Q; Xu Y; Jin W; Wang Y
    World J Surg Oncol; 2023 Jun; 21(1):191. PubMed ID: 37349737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: Long-term oncologic outcomes after standard resection.
    Sahakyan MA; Kim SC; Kleive D; Kazaryan AM; Song KB; Ignjatovic D; Buanes T; Røsok BI; Labori KJ; Edwin B
    Surgery; 2017 Oct; 162(4):802-811. PubMed ID: 28756944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma.
    Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
    Scand J Gastroenterol; 2019 Jun; 54(6):780-786. PubMed ID: 31180790
    [No Abstract]   [Full Text] [Related]  

  • 20. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.